Hims & Hers Health stock tanks
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's Q3 2024 revenue is expected to exceed projections as concerns rise over compounded GLP-1 medications.
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List
Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs are no longer on its list of drugs in short supply.
The FDA issued a warning about compounding pharmacies on weight-loss drugs
A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies against skirting regulatory standards to put them on the market now that shortages are waning.
What end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand.
TipRanks on MSN18h
HIMS Stock Rises 208% in a Year and Is Ready to Compete with the Big Guns
As a player in the growing telehealth sector, Hims & Hers Health ($HIMS) has grown significantly, driving its stock up over ...
bovnews1d
The Hims & Hers Health Inc Enigma: What’s Causing the Wild Swings in HIMS Stock?
Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $17.66 which represents a slight increase of $0.53 or 3.09% from the prior close of $17.13. The stock opened at $17.55 and ...
Hims & Hers Is Unbelievably Cheap And Profitable: Buy Now
Hims & Hers is a fantastic value despite its high on-the-surface P/E ratio and valuation metrics. Click here to read why HIMS ...
24/7 Wall St2d
Hims & Hers Health Inc - Class A
Hims & Hers Health Inc is a telehealth company based in San Francisco, California, providing a bridge between consumers and licensed healthcare professionals across the U.S., the U.K., and other ...
Costco, Hims, Noom, and more: 6 companies that started hawking weight loss products this year
Exploding sales of prescription weight loss medications have catapulted Novo Nordisk (NVO) and Eli Lilly (LLY) to become the ...
Is Hims & Hers rally at risk as GLP-1 shortages ease?
Hims & Hers' (HIMS) stock drop marks the latest overhang on a company that has more than doubled in value over the past 12 ...
Yahoo Finance4d
Hims & Hers Health Set to Join S&P SmallCap 600
NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health ... Effective Date Index Name Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 ...
3-Stock Lunch: Nvidia, Levi Strauss & Co & Hims & Hers Health Inc
Fox News' Bryan Llenas reports from the picket line at Red Hook Terminal in New York on the union's demands and impact of the ...
Investing5d
Hims & Hers health CEO sells over $6 million in company stock
Andrew Dudum, the Chief Executive Officer of Hims & Hers Health, Inc. (NYSE:HIMS), has recently sold a significant portion of his company stock, according to a new filing with the Securities and ...
Is the soaring Hims & Hers stock a good investment?
Hims & Hers (NASDAQ: HIMS) stock has done well since the company went public a few years ago. It has soared by over 193% in ...